期刊文献+

老年高血压合并阵发性心房颤动患者血浆脑钠肽水平及P波离散度的临床观察 被引量:2

Clinical study on plasma levels of brain natriuretic peptide or P wave dispersion on the prediction of paroxysmal atrial fibrillation in the elderly patients with essential hypertension
下载PDF
导出
摘要 目的:探讨P波离散度(Pd)和血浆脑钠肽水平(BNP)预测老年高血压病患者伴发的阵发性心房颤动的发生。方法:观察34例有阵发性心房颤动的老年高血压病患者(A组,平均年龄70岁)的血浆BNP水平、最大P波时限(Pmax)、最小P波时限(Pmin)、Pd、左房内径(LAD)和左室射血分数(LVEF),并与34例无阵发性心房颤动病史的高血压病患者(B组,平均年龄71岁)比较。结果:血浆BNP水平:A组显著高于B组,(63.75±54.29)ng/L比(32.72±23.37)ng/L,P<0.01;Pd:A组显著高于B组,(69.72±25.04)ms比(28.22±14.15)ms,P<0.001;PmaxA组显著高于B组,(140.02±20.15)ms比(110.35±18.83)ms,P<0.001;LVEF:A组显著低于B组,(61.84±9.01)%比(67.72±5.18)%,P<0.05;Pmin、LAD两组差别无统计学差异。结论:血浆BNP水平和Pd均能预测老年高血压病患者伴发的阵发性心房颤动的发生。 Objective: To explore whether the risk of paroxysmal atrial fibrillation(PAF) of old patients with essential hypertension could be identified by plasma levels of brain natriuretic peptide (BNP) or left atrial dispersion (Pd).Methods: The plasma levels of brain natriuretic peptide(BNP),the maximum of P wave duration (Pmax), the minimum of P wave duration (Pmin),and the P wave dispersion (Pd = Pmax-Pmin)from the 12-leads surface electrocardiogram of 34 old essential hypertensive patients with history of PAF (group A,mean age 70) and 34 elderly essential hypertensive patients without history of PAF (group B ,mean age 71), and left ventricular ejection fraction (LVEF) were measured by echocardiogryphy,Results:Plasma levels of BNP,Pmax and Pd were significantly higher in group A than those in group B ( BNP,67.35 ± 54.29 ng/dl vs 32.72± 23.37 ng/dl, P 〈 0.01 ;Pmax, 140.02 ±20,15 ms vs 110.35± 18,83 ms,P〈 0.001 ; Pd,69.72±25.04 ms vs 28.22±14.15 ms, P〈 0.001); LVEF was significanty lower in group A than that in group B[(61.84 ± 9.01)% vs (67.72± 5.18)%, P 〈 0.05 ].Conclusion: Plasma levels of BNP and Pd may be usded for the prediction of the risk of developing PAF in old essential hypertensive patients.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2005年第11期817-818,826,共3页 Journal of Nanjing Medical University(Natural Sciences)
关键词 心房颤动 脑钠肽 P波离散度 高血压 老年 paroxysmal atrial fibrillation brain natriuretic peptide P wave dispersion old hypertension
  • 相关文献

参考文献8

  • 1Ozer N, Aytemir K, Aralar E, et al. P wave dispersion in hypertensive patients with paroxysmal atrial fibrillation[J].PACE, 2000,23:1859-1862.
  • 2魏仁敏,于海初,蔡尚郎.高血压并发阵发性心房颤动患者P波离散度的临床研究[J].中华心血管病杂志,2003,31(10):739-741. 被引量:29
  • 3Amalia H,Kostas T,Marina T,et al. BNP plasma levels or left atrial dimension for the prediction of paroxysmal atrial fibrillation in subjects with essential hypertension[J] ? Am Heart J,2004,17:228.
  • 4Patrick TEllinor,Adrian FLow,Kristen K,et al. Discordent atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation [J]. J Am Coll Cardio,2005,45: 82-86.
  • 5Dilaveris PE, Gialafos EJ, Sideris SL,et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation [J]. Am Heart J,1998,135:733-738.
  • 6Chugh SS, Blackshear JL, Shen WK,et al.Epidemiology and natural history of atrial fibrillation :clinical implications[J]. J Am Coll Cardiol,2001,37:371-378.
  • 7Duytschaever M,Blaauw Y,Allessie M. Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class Ⅲ drugs [J]. Cardiovasc Res,2005,67(1): 69-76.
  • 8Maisel A,Krishnaswamy P,Nawak R,et al.Rapid Measurement of B-Type Natriuretic Peptide in Emergency Diagnosis of Heart Failure [J]. N Engl J Med ,2002,347:161-167.

共引文献28

同被引文献18

  • 1Lemos JAd, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease [ J ]. Lancet, 2003,362 (26) :316-322
  • 2Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult:executive summary a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee to revise the 1995 guidelines for the evaluation and management of heart failure) [ J ]. Circulation, 2001,104(24) : 2996-3007
  • 3Norton CK, Karen Kesten. An Update on the treatment of heart failure using biventricular pacing and intravenous nesiritide [J]. Journal of Emergency Nursing,2005,31 (1):76-79
  • 4Byoung J. Nesiritide-vs-Nitroglycerin (VMAC Trial) [J]. JAMA, 2004,287(12) : 1531-1540
  • 5WF P, CL E, MA S. Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure[J]. Am J Emerg Med,2005,23 (12) :327- 331
  • 6Medicine tESoIC. Guidelines on the diagnosis and treatment of acute heart failure [J]. European Heart Journal, 2005,10(3) : 1-36
  • 7Critchley LA, Peng ZY, Fok BS, et at. Testing the reliability of a new ultrasonic cardiac output monitor; the USCOM, by using aortic flowprobes in anesthetized dogs[J]. Anesth Analg, 2005,100(4) : 748-753
  • 8Knobloch K. No difference in the hemodynamic response to nordic pole walking vs.conventional brisk walking-A randomized exercise field test using the ultrasonic cardiac output monitor (USCOM)[J]. International journal of Cardiology, 2007,7( 1 ) : 142-146
  • 9Mills RM,LeJemtel TH,Horton DP. Sustained hemodynamic effects of an infusion of nesiritide (Human b-Type Natriuretic Peptide) in heart failure [J]. Journal of the American College of Cardiology, 1999,34( 1 ) : 155-162
  • 10Schreiner GF, Protter AA. B-type natriuretic peptide for the treatment of congestive heart failure[J]. Cardiovascular and renal , 2004,2 ( 1 ) : 142-147

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部